// App-Quantinova.ai

3075 : Immunornase Therapy Of Lymphoma With Novel CD22-Targeting Quadruple Ranpirnase

Researchers

Presenter

  • Donglin Liu

Principal Investigators

  • Thomas M Cardillo

  • David M Goldenberg

  • Chien-Hsing Chang

Medical Centers

  • Garden State Cancer Center, Center for Molecular Medicine and Immunology, Morris Plains, NJ

Locations

  • United States

Companies

  • IBC Pharmaceuticals,

  • Immunomedics, Inc.

Study Components

Therapeutic Area

  • Genetic Disorder

  • Dermatology

Disease

  • Acute lymphoblastic leukemia

  • Mantle cell lymphoma

  • Burkitt lymphoma

  • Lymphomas

  • Multiple Myeloma

  • Dowling-Degos disease 2

Biomarkers

  • Peripheral blood mononuclear cell

  • Cyclic AMP-dependent protein kinase

  • Cytokeratin 5

Drug/Treatment

  • Epratuzumab

  • ranpirnase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved